892511319	892511319	CD	B-NP	O
|	|	NNP	I-NP	O
RMPMHHS	RMPMHHS	NNP	I-NP	O
|	|	VBD	B-VP	O
60640609	60640609	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1153114	1153114	CD	B-NP	O
|	|	CC	I-NP	O
11/25/2004	11/25/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHRONIC	CHRONIC	NNP	I-NP	I-protein
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	I-protein
PULMONARY	PULMONARY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/4/2004	2/4/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/17/2004	2/17/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
OMAR	OMAR	NNP	B-NP	O
SOMMESE	SOMMESE	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
AND	AND	NNP	I-NP	O
TIME	TIME	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
2/17/2004	2/17/2004	CD	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Ant	Ant	NNP	B-NP	O
University	University	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DATE	DATE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	I-VP	O
Trote	Trote	VB	I-VP	O
Hospital	Hospital	NN	B-NP	O
on	on	IN	B-PP	O
2/4/2004	2/4/2004	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
unit	unit	NN	I-NP	O
on	on	IN	B-PP	O
6/29/2004	6/29/2004	CD	B-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Biand	Biand	NNP	B-NP	O
Valley	Valley	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypercarbia	hypercarbia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Medical	Medical	NNP	B-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
with	with	IN	B-PP	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
venostasis	venostasis	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
,	,	,	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
1999	1999	CD	I-NP	O
three	three	CD	I-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
80-pack-year	80-pack-year	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
80-pack-year	80-pack-year	JJ	B-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Astine	Astine	NNP	B-NP	O
Emount	Emount	NNP	I-NP	O
Wallca	Wallca	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
2/4/2004	2/4/2004	CD	B-NP	O
with	with	IN	B-PP	O
drowsiness	drowsiness	NN	B-NP	O
and	and	CC	O	O
slurred	slur	VBD	B-VP	O
speech	speech	NN	B-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
ABG	ABG	NN	I-NP	O
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
of	of	IN	B-PP	O
7.25	7.25	CD	B-NP	O
,	,	,	O	O
PCO2	PCO2	NN	B-NP	B-protein
of	of	IN	B-PP	O
82	82	CD	B-NP	O
,	,	,	O	O
PO2	PO2	NN	B-NP	O
of	of	IN	B-PP	O
56	56	CD	B-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
87	87	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
quickly	quickly	RB	B-ADVP	O
awakened	awaken	VBD	B-VP	O
after	after	IN	B-SBAR	O
Narcan	Narcan	NN	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
opiates	opiate	NNS	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
hypercarbia	hypercarbia	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
opiate	opiate	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
COPD	COPD	NN	B-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
80-pack-year	80-pack-year	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
history	history	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
normally	normally	RB	B-ADVP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
gentle	gentle	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
suffers	suffer	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Percocet	Percocet	NNP	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
improving	improve	VBG	I-VP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gasses	gas	NNS	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
and	and	CC	O	O
improved	improve	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
6/29/2004	6/29/2004	CD	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
breathless	breathless	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
pulseless	pulseless	JJ	I-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
ABG	ABG	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
7.04	7.04	CD	B-NP	O
,	,	,	O	O
PCO2	PCO2	NN	B-NP	B-protein
of	of	IN	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
PO2	PO2	NN	B-NP	O
of	of	IN	B-PP	O
47	47	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
sating	sate	VBG	I-VP	O
54	54	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ACLS	ACLS	NN	I-NP	B-protein
code	code	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
atropine	atropine	NN	I-NP	O
and	and	CC	O	O
0.04	0.04	CD	B-NP	O
of	of	IN	B-PP	O
Narcan	Narcan	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
aspirating	aspirate	VBG	I-VP	O
when	when	WRB	B-ADVP	O
intubated	intubate	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
until	until	IN	B-PP	O
2/17/2004	2/17/2004	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
questionable	questionable	JJ	B-NP	O
penicillin	penicillin	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
with	with	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
Hispanic	Hispanic	JJ	I-NP	O
male	male	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
sedated	sedate	VBN	I-VP	O
and	and	CC	I-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
responds	respond	VBZ	B-VP	O
to	to	TO	B-PP	O
commands	command	NNS	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
oriented	orient	VBN	I-VP	O
to	to	TO	I-VP	O
voice	voice	VB	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
skin	skin	NN	I-NP	O
showed	show	VBD	B-VP	O
his	his	PRP$	B-NP	B-DNA
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
venostasis	venostasis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
erythema	erythema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
,	,	,	O	O
nonpitting	nonpitting	JJ	B-NP	O
edema	edema	NN	I-NP	O
bilateral	bilateral	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
and	and	CC	I-NP	O
induration	induration	NN	I-NP	O
of	of	IN	B-PP	O
skin	skin	NN	B-NP	O
on	on	IN	B-PP	O
legs	leg	NNS	B-NP	O
,	,	,	O	O
medial	medial	JJ	B-NP	O
thigh	thigh	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
popliteal	popliteal	JJ	I-NP	O
fossae	fossa	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
had	have	VBD	B-VP	O
onychomycosis	onychomycosis	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
clearcut	clearcut	NN	I-NP	O
abrasions	abrasion	NNS	I-NP	O
or	or	CC	I-NP	O
cuts	cut	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
skin	skin	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
ecchymoses	ecchymosis	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
weeping	weep	VBG	B-VP	O
plaque	plaque	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
at	at	IN	B-PP	O
heparin	heparin	NN	B-NP	B-DNA
injection	injection	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
subclavian	subclavian	JJ	I-NP	O
line	line	NN	I-NP	O
was	be	VBD	B-VP	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nonerythematous	nonerythematous	JJ	I-ADJP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
leaking	leak	VBG	I-NP	O
port	port	NN	I-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodations	accommodation	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
endotracheal	endotracheal	JJ	I-NP	O
tube	tube	NN	I-NP	O
and	and	CC	I-NP	O
OG	OG	NN	I-NP	O
tube	tube	NN	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
chest	ch	JJS	I-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
anteriorly	anteriorly	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
laterally	laterally	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
wheezing	wheeze	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	B-cell_line
midclavicular	midclavicular	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
were	be	VBD	B-VP	O
heard	hear	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
panus	panus	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
appreciable	appreciable	JJ	I-NP	O
organomegaly	organomegaly	NN	I-NP	O
,	,	,	O	O
tenderness	tenderness	NN	B-NP	O
and	and	CC	O	O
hyperactive	hyperactive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
moving	move	VBG	I-VP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
extremities	extremity	NNS	I-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
were	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
anomalies	anomaly	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
140	140	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
104	104	CD	B-NP	O
,	,	,	O	O
carbon	carbon	NN	B-NP	O
dioxide	dioxide	NN	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
153	153	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ionized	ionize	VBN	I-NP	O
calcium	calcium	NN	I-NP	O
of	of	IN	B-PP	O
1.04	1.04	CD	B-NP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	I-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
per	per	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
signs	sign	NNS	B-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
and	and	CC	I-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
likely	likely	RB	B-ADVP	O
was	be	VBD	B-VP	O
hypercarbic	hypercarbic	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
hypercarbic	hypercarbic	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
occurred	occur	VBD	B-VP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
where	where	WRB	B-ADVP	O
opiates	opiate	NNS	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
administered	administer	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
improbable	improbable	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
arrest	arrest	NN	I-NP	O
happened	happen	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
opiate	opiate	VB	I-VP	O
ingestion	ingestion	NN	B-NP	O
rather	rather	RB	B-NP	O
patient	patient	NN	I-NP	O
likely	likely	RB	B-ADJP	O
had	have	VBD	B-VP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
CAD	CAD	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
very	very	RB	B-NP	O
significant	significant	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
aztreonam	aztreonam	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
Atrovent	Atrovent	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
.	.	.	O	O

Aggressive	Aggressive	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
provided	provide	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
after	after	IN	B-PP	O
completing	complete	VBG	B-VP	O
his	his	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
MRSA	MRSA	NN	B-NP	O
growing	grow	VBG	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
MRSA	MRSA	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
help	help	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
significant	significant	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
typically	typically	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
at	at	IN	B-PP	O
1-2	1-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
taken	take	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neighborhood	neighborhood	NN	I-NP	O
of	of	IN	B-PP	O
15-20	15-20	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
likely	likely	RB	B-ADJP	O
remarkably	remarkably	RB	B-VP	O
helped	help	VBD	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
breathing	breathing	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
and	and	CC	I-NP	O
peg	peg	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
8/27/04	8/27/04	CD	B-NP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
breathing	breathing	NN	B-NP	O
on	on	IN	B-PP	O
trache	trache	NN	B-NP	O
collar	collar	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
6/11/04	6/11/04	CD	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
breathing	breathe	VBG	I-VP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
time	time	NN	I-NP	O
successfully	successfully	RB	B-ADVP	O
on	on	IN	B-PP	O
trache	trache	NN	B-NP	O
collar	collar	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
colonized	colonize	VBN	I-VP	O
with	with	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
and	and	CC	I-NP	O
VSE	VSE	NN	I-NP	B-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
MICU	MICU	NN	I-NP	O
admission	admission	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
sensitive	sensitive	JJ	I-NP	O
enterococcal	enterococcal	JJ	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	I-NP	O
aztreonam	aztreonam	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
MRSA	MRSA	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cultures	culture	NNS	I-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
CAD	CAD	NN	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
mostly	mostly	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
38	38	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
3.9	3.9	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

Presumably	Presumably	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
adversely	adversely	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
day	day	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
plus	plus	CC	O	O
requiring	require	VBG	B-VP	O
additional	additional	JJ	B-NP	O
insulin	insulin	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
proxy	proxy	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
Picot	Picot	NNP	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
actively	actively	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

NUTRITION	NUTRITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
on	on	IN	B-PP	O
Jevity	Jevity	NNP	B-NP	O
tube	tube	NNP	I-NP	O
feeds	feed	VBZ	B-VP	O
during	during	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
clean	clean	JJ	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
insertion	insertion	NN	B-NP	O
.	.	.	O	O

GJ	GJ	NN	B-NP	O
tube	tube	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
clean	clean	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

Clear	Clear	JJ	B-NP	O
sounding	sound	VBG	I-NP	O
lungs	lung	NNS	I-NP	O
with	with	IN	B-PP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
heard	hear	VBN	I-VP	O
more	more	RBR	B-ADVP	O
extensively	extensively	RB	I-ADVP	O
than	than	IN	B-PP	O
before	before	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
resolving	resolve	VBG	B-VP	O
chronic	chronic	JJ	B-NP	O
venostasis	venostasis	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
exceptions	exception	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
exam	exam	NN	I-NP	O
remain	remain	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
interactive	interactive	JJ	B-ADJP	O
,	,	,	I-ADJP	O
alert	alert	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATION	MEDICATION	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
acetylsalicylic	acetylsalicylic	JJ	B-NP	O
acid	acid	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
hold	hold	NN	B-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
topical	topical	JJ	B-NP	O
patch	patch	NN	I-NP	O
,	,	,	O	O
change	change	VB	B-VP	O
every	every	DT	B-NP	O
72	72	CD	I-NP	O
hours	hour	NNS	I-NP	O
or	or	CC	O	O
hold	hold	VB	B-VP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Haldol	Haldol	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
subcutaneous	subcutaneous	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
110	110	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
111	111	CD	B-NP	O
and	and	CC	I-NP	O
130	130	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
131	131	CD	B-NP	O
and	and	CC	I-NP	O
150	150	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
151	151	CD	B-NP	O
and	and	CC	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
201	201	CD	B-NP	O
and	and	CC	I-NP	O
250	250	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
four	four	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
251	251	CD	B-NP	O
and	and	CC	I-NP	O
300	300	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-NP	O
301	301	CD	I-NP	O
and	and	CC	I-NP	O
350	350	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
351	351	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
contact	contact	VBP	B-VP	O
the	the	DT	B-NP	O
officer	officer	NN	I-NP	O
.	.	.	O	O

Lactulose	Lactulose	FW	B-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	IN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
or	or	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
55	55	CD	I-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tabs	tab	NNS	I-NP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamins	multivitamin	NNS	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
avoid	avoid	VB	B-VP	O
grape	grape	NN	B-NP	O
juice	juice	NN	I-NP	O
or	or	CC	O	O
grape	grape	NN	B-NP	O
fruit	fruit	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
everyday	everyday	JJ	I-NP	O
,	,	,	I-NP	O
K-Dur	K-Dur	JJ	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zyprexa	Zyprexa	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
G	G	NN	I-NP	O
tube	tube	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
TP	TP	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
80	80	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.h.s.	q.h.s.	RB	I-ADVP	O
,	,	,	O	O
please	please	NN	B-NP	O
give	give	VBP	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
half	half	PDT	B-NP	O
a	a	DT	I-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
q.	q.	NNP	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
Khachatoorian	Khachatoorian	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-4998354	8-4998354	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BASTARDI	BASTARDI	NNP	B-NP	O
,	,	,	O	O
PETE	PETE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RUMMELL	RUMMELL	NN	B-NP	O
,	,	,	O	O
KENDALL	KENDALL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4512354	4512354	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/20/04	3/20/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/20/04	3/20/04	CD	B-NP	O

